Skip to content

Evaluation of the Efficacy of LITE Devices in Patients with AECOPD

Evaluation of the Efficacy of LITE Devices in Patients with AECOPD

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093005
Enrollment
Unknown
Registered
2024-11-27
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute exacerbation of chronic obstructive pulmonary disease, AECOPD

Interventions

Experimental group:In addition to receiving routine COPD treatment, use LITE equipment twice a day for 15-20 minutes each time. The use of LITE devices will be independently completed by participants
2. Guide the patient to inhale deeply to 3/4 of the maximum inspiratory volume or at least inhale harder than usual, hold for 2-3 seconds, and then continue to exhale slowly until the functional resid
3. Remove the device and cough "Huff" 2-3 times. One group in the morning and one group in the evening, with each group lasting 15-20 minutes, and intervention until the end of follow-up.
Control group:Conventional treatment conventional therapy

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the COPD diagnostic criteria of the 2024 Global Initiative for Chronic Obstructive Lung Disease (GOLD Guidelines), with a GOLD classification of 2-4, and meet the definition of acute exacerbation; 2.Age: 18-80 years old; Gender is not limited; 3.The frequency of expectoration is more than 5 times per day, and the duration of each expectoration is more than 30 seconds; 4.Able to understand and cooperate with the use of Lite devices 5.The patient or family member has a full understanding of the purpose and significance of this experiment, voluntarily participates in the study, and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women; 2.Respiratory active bleeding; 3.Mental disorders, unable to cooperate with the experimenter.

Design outcomes

Primary

MeasureTime frame
Forced vital capacity, FVC;Forced Expiratory Volume in the first second,FEV1;Peak expiratory flow ,PEF;White blood cell count;Neutrophil percentage;C-reactive protein;PaCO2;PaO2;

Secondary

MeasureTime frame
Modified Medical Research Council,mMRC;Cough Assessment Tool;

Countries

China

Contacts

Public ContactYugang Zhuang

Shanghai Tenth People's Hospital

zhuangyg07@sina.com+86 189 1768 7597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026